Publications

Year

Identification of metastasis-suppressive microRNAs in primary melanoma

Hanniford, D., Segura, M. F., Zhong, J., Philips, E., Jirau-Serrano, X., Darvishian, F., Berman, R. S., Shapiro, R. L., Pavlick, A. C., Brown, B., Osman, I., & Hernando, E. (2015). Journal of the National Cancer Institute, 107(3), dju494.

PMID: 25677173

Limited miR-17-92 overexpression drives hematologic malignancies

Danielson, L. S., Reavie, L., Coussens, M., Davalos, V., Castillo-Martin, M., Guijarro, M. V., Coffre, M., Cordon-Cardo, C., Aifantis, I., Ibrahim, S., Liu, C., *Koralov, S. B., & *Hernando, E. (2015). Leukemia research, 39(3), 335–341.

PMID: 25597017

BRD4 regulates embryonic stem cell identity by controlling transcriptional elongation of super-enhancer associated pluripotency genes

Di Micco, R., Fontanals-Cirera, B., Low, V., Ntziachristos, P., Yuen, S. K., Lovell, C. D., Dolgalev, I., Yonekubo, Y., Zhang, G., Rusinova, E., Gerona-Navarro, G., Cañamero, M., Ohlmeyer, M., Aifantis, I., Zhou, M. M., Tsirigos, A., & Hernando, E. (2014). Cell reports, 9(1), 234–247.

PMID: 25263550

Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients

Fleming, N. H., Zhong, J., da Silva, I. P., Vega-Saenz de Miera, E., Brady, B., Han, S. W., Hanniford, D., Wang, J., Shapiro, R. L., Hernando, E., & Osman, I. (2015). Cancer, 121(1), 51–59.

PMID: 25155861

Anti-miR-182 reduces ovarian cancer burden, invasion and metastasis: an in vivo study in orthotopic xenografts of nude mice

Xu, X., Ayub, B., Liu, Z., Serna, V. A., Qiang, W., Liu, Y., Hernando, E., Zabludoff, S., Kurita, T., Kong, B., & Wei, J. J. (2014). Molecular cancer therapeutics, 13(7), 1729–1739.

PMID: 24825857

Hedgehog pathway blockade inhibits melanoma cell growth in vitro and in vivo

O’Reilly, K. E., de Miera, E. V., Segura, M. F., Friedman, E., Poliseno, L., Han, S. W., Zhong, J., Zavadil, J., Pavlick, A., Hernando, E., & Osman, I. (2013). Pharmaceuticals (Basel, Switzerland), 6(11), 1429–1450.

PMID: 24287465

Clinicopathological characteristics at primary melanoma diagnosis at risk factors for brain metastasis

Qian, M., Ma, M. W., Fleming, N. H., Lackaye, D. J., Hernando, E., Osman, I., & Shao, Y. (2013). Melanoma research, 23(6), 461–467.

PMID: 24165034

BRD4 sustains proliferation and represents a new target for epigenetic therapy in melanoma

Segura, M. F., Fontanals-Cirera, B., Gaziel-Sovran, A., Guijarro, M. V., Hanniford, D., Zhang, G., González-Gomez, P., Morante, M., Jubierre, L., Zhang, W., Darvishian, F., Ohlmeyer, M., Osman, I., Zhou, M. M., & Hernando, E. (2013). Cancer research, 73(20), 6264–6276.

PMID: 23950209

Development and Characterization of a Clinically Relevant Mouse Model of Melanoma Brain Metastasis

Morsi, A., Gaziel-Sovran, A., Cruz-Munoz, W., Kerbel, R. S., Golfinos, J. G., Hernando, E., & Wadghiri, Y. Z. (2013). Pigment cell & melanoma research, 26(5), 743–745.

PMID: 23647875

Dual Pten/p53 suppression promotes sarcoma progression by triggering Notch signaling

Guijarro, M. V., Dahiya, S., Danielson, L. S., Segura, M. F., Vales-Lara, F. M., Menendez, S., Popiolek, D., Mittal, K., Wei, J. J., Zavadil, J., Cordon-Cardo, C., Pandolfi, P. P., & Hernando, E. (2013). The American journal of pathology, 182(6), 2015–2027.

PMID: 23708211

FBH1 protects melanocytes from transformation and is deregulated in melanomas

Jeong, Y. T., Cermak, L., Guijarro, M. V., Hernando, E., & Pagano, M. (2013). Cell cycle (Georgetown, Tex.), 12(7), 1128–1132.

PMID: 23466708